A newly synthesised molybdenum/ascorbic acid complex alleviates some effects of cardiomyopathy in streptozocin-induced diabetic rats

Drugs in R and D

Volumn 7, Issue 1, 2006, Pages 33-42

  MacDonald, K ^a   Bailey, J ^a   MacRory, C ^a   Friis, C ^a   Vogels, C M ^a   Broderick, T ^b   Westcott, S A ^a  

^a MOUNT ALLISON UNIVERSITY   (Canada)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; BIS(ASCORBIC ACID)DIOXOMOLYBDENUM; DRINKING WATER; GLUCOSE; LIPID; MOLYBDENUM COMPLEX; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CARDIOMYOPATHY; CONTROLLED STUDY; CONVALESCENCE; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART STRESS; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASCORBIC ACID; BLOOD GLUCOSE; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; HEART; INSULIN; LIPIDS; MALE; MOLYBDENUM; MYOCARDIAL ISCHEMIA; RATS; RATS, INBRED STRAINS; STREPTOZOCIN;

EID: 32244440636     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200607010-00003     Document Type: Article

References (25)

1. Hadley ME. Endocrinology. 4th ed. Upper Saddle River (NJ): Prentice Hall, 1982
2. Youngren JF, Goldfine ID. The molecular basis of insulin resistance. Science and Medicine, 1997 May/Jun; 18-27
3. Brichard S, Henquin JC. The role of vanadium in the management of diabetes. Trends Pharmacol Sci 1995; 16: 265-70
4. Guyton CG, Hall JE. Textbook of medical physiology. 9th ed. Philadelphia (PA): WB Saunders Company, 1996
5. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996; 7: 116-23
6. Trueblood N, Ramasamy R. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol 1998; 275 (1 Pt 2): H75-83
7. Dhalla NS, Pierce GN, Innes IR, et al. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1985; 1: 263-81
8. Yuen VG, Orvig C, Thompson KH, et al. Improvement in cardiac dysfunction in streptozocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovandium (IV). Can J Physiol Pharmacol 1992; 71: 270-6
9. Thompson KH, McNeill JH, Orvig C. Vanadium compounds as insulin mimics. Chem Rev 1999; 99: 2561-71
10. Rajagopalan KV. Molybdenum: an essential trace element. Nutr Rev 1987; 45: 321-8
11. Ozcelikay AT, Becker DJ, Ongemba LN, et al. Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. Am J Physiol 1996; 270: E344-52
12. Fillat C, Rodriguez-Gil JE, Guinovart JJ. Molybdate and tungstate act like vanadate on glucose metabolism in isolated hepatocytes. Biochem J 1992; 282: 659-63
13. Lord SJ, Epstein NA, Paddock RL, et al. Synthesis, characterization, and biological relevance of hydroxypyron and hydroxypyridinone complexes of molybdenum. Can J Chem 1999; 77: 1249-61
14. Singh RB, Mohammad NA, Agarwal P, et al. Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diabet Assoc 1995; 95: 775-83
15. Munson M, Lee Y. Natural nitro? Prevention; Emmaus 1996; 48: 25
16. Nyyssonen K, Parviainen MT, Salonen R, et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314 (7081): 634-8
17. Dai S, McNeill JH. Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozocin-diabetic rats. Diabet Res Clin Pract 1995; 27: 11-8
18. Nicholl TA, Lopaschuk GD, McNeill JH. Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart. Am J Physiol 1991; 266: H1053-9
19. Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res 1995; 29: 373-8
20. Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1994; 1225: 191-4
21. Maddaford TG, Russell JC, Pierce GN. Postischemic cardiac performance in the insulin resistant JCR: LA-cp rat. Am J Physiol 1997; 273: H1187-92
22. Rodrigues B, Goyal RK, McNeill JH. Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther 1986; 237: 292-9
23. Liedtke AJ, Nellis SH, Mjos OD. Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 1983; 247: H387-94
24. Wall SR, Lopaschuk GD. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochem Biophys Acta 1989; 10006: 97-103
25. Neely JR, Morgan HE. Relationship between carbohydrate metabolism and energy balance of heart muscle. Ann Rev Physiol 1974; 36: 413-59